These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 8238135

  • 1. Surfactant replacement therapy in utero for prevention of hyaline membrane disease in the preterm baboon.
    Galan HL, Cipriani C, Coalson JJ, Bean JD, Collier G, Kuehl TJ.
    Am J Obstet Gynecol; 1993 Oct; 169(4):817-24. PubMed ID: 8238135
    [Abstract] [Full Text] [Related]

  • 2. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D, Maeta H, Raju TN, John E, Bhat R, Go M, Dahiya U, Roberson Y, Yamin A, Narula A.
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [Abstract] [Full Text] [Related]

  • 3. Early and late surfactant treatments in baboon model of hyaline membrane disease.
    Maeta H, Vidyasagar D, Raju TN, Bhat R, Matsuda H.
    Pediatrics; 1988 Feb; 81(2):277-83. PubMed ID: 3340477
    [Abstract] [Full Text] [Related]

  • 4. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
    Shimada S, Raju TN, Bhat R, Maeta H, Vidyasagar D.
    Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035
    [Abstract] [Full Text] [Related]

  • 5. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
    Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ.
    J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097
    [Abstract] [Full Text] [Related]

  • 6. The prevention of hyaline membrane disease (HMD) in the preterm fetal lamb through the static inflation of the lungs: the conditioning of the fetal lungs.
    Kolobow T, Solca M, Presenti A, Buckhold D, Pierce JD.
    Trans Am Soc Artif Intern Organs; 1980 Jan; 26():567-72. PubMed ID: 6910328
    [Abstract] [Full Text] [Related]

  • 7. Effect of exogenous surfactant on the development of bronchopulmonary dysplasia in a baboon hyaline membrane disease model.
    Maeta H, Raju TN, Vidyasagar D, Bhat R, Esterly J, Matsuda H, Shimada S, Krukenkamp IB, Shanklin DR.
    Crit Care Med; 1990 Apr; 18(4):403-9. PubMed ID: 2318051
    [Abstract] [Full Text] [Related]

  • 8. Hyaline membrane disease. Effect of surfactant prophylaxis on lung morphology in premature primates.
    Cutz E, Enhörning G, Robertson B, Sherwood WG, Hill DE.
    Am J Pathol; 1978 Sep; 92(3):581-94. PubMed ID: 99046
    [Abstract] [Full Text] [Related]

  • 9. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
    Galan HL, Kuehl TJ.
    Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
    [Abstract] [Full Text] [Related]

  • 10. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants.
    Namgung R, Lee C, Suh JS, Park KI, Han DG.
    Yonsei Med J; 1989 Dec; 30(4):355-66. PubMed ID: 2697112
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ventilation-perfusion relationships in preterm infants after surfactant treatment.
    Bowen W, Martin CR, Krauss AN, Auld PA.
    Pediatr Pulmonol; 1994 Sep; 18(3):155-62. PubMed ID: 7800432
    [Abstract] [Full Text] [Related]

  • 14. The artificially ventilated preterm rabbit neonate as experimental model of hyaline membrane disease.
    Nilsson R.
    Acta Anaesthesiol Scand; 1982 Apr; 26(2):89-103. PubMed ID: 7048842
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW.
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.